PPIG and tuberculosis: Within the limits of present study anti-TB drug RFM is widely known for its effect to induce CYP system, therefore, reducing the serum /plasma concentrations of other co-administered drugs that are CYP substrates and thereby reducing their therapeutic efficacy.